What We’ve Learned From Four Years of Diving Into Dollars for Docs – ProPublica.
Of the hundreds of thousands of physicians who have received, 3.4 million payments totaling $4 billion from pharmaceutical companies, here are my stats:
- Number of times I’m in this database: 0
- Number of payments I’ve received: 0
- Amount of payments from pharmaceutical companies or device manufacturers made to me: $0.00
- When I will next appear in this database: Never
“Why are my medications so expensive? Look at that free stethoscope* around your neck.” – Patient instructor at my medical school
“This information might be useful to you during the free drug lunch that you don’t pay for until later.” – Pharmacology professor at my medical school
My conflict of interest statement is here. Feel free to copy it. Life’s better when it’s conflict free.
*Stethoscope immediately sent to Central America where it was needed, thanks American Medical Student Association 🙂
I have alluded to the excellent Sustainable DC Plan and have been planning to post about it, and then realized I hadn’t put this up yet. It’s my first assignment from the course I took on navigating climate change conversations (that I highly recommend, it’s free – see: Finished my 3rd MOOC, and moving to renewable Energy in Washington, DC | Ted Eytan, MD).
Climate change-mediated effects on the environment in may worsen the burden allergies in the Washington, DC, area, with significant health and economic impact, and amplifying feedbacks in the form of pharmaceutical use.
The thing about allergy disease as it relates to climate change is that:
- The only way to mitigate the health and economic damage that comes from allergy exposure it to stop climate change – it’s not an air quality issue, it’s an issue of the way plants behave
- The health and economic damage to a working population is significant, a lot more than asthma, more than cancer, more than diabetes, less than hypertension, less than heart disease, less than hypertension – check out the chart within the document above.
I included my personal allergy story in the assignment – no data without stories, no stories without data 🙂
Enjoy, comments welcome – Feel free to check out the Sustainable DC Plan in the meantime.
Kaiser Permanente Statement on Verdict in Neurontin Case | Kaiser Permanente News Center.
I did not know this action was under way and I am impressed with the result. I have to say as someone who has been fortunate to practice in health systems that evaluate the evidence behind therapies before adopting them that it’s great to know there is support for doing right for people rather than more for people.